AS
ASH.US Ashland Global Holdings Inc
- Market cap
- USD 3.50B
- P/E
- 139.0x
- P/B
- 1.87x
- ROE
- 0.2%
- Dividend yield
- 2.20%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Sep 2026.
Is ASH.US undervalued?
Graham numberThe Graham number of Ashland Global Holdings Inc cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Ashland Global Holdings Inc fundamental analysis
No fundamental analysis for Ashland Global Holdings Inc yet.
Ashland Global Holdings Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Ashland Global Holdings Inc
Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, …
Full company profileAshland Global Holdings Inc financial statements
Ashland Global Holdings Inc annual financial statements
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 2.31B | 2.59B | 2.15B | 2.02B | 2.11B | 2.39B | 2.19B | 2.11B | 1.82B | 1.86B |
| Gross Profit | 729M | 863M | 651M | 599M | 670M | 830M | 668M | 618M | 549M | 601M |
| Operating Income | 49.0M | 102M | 86.0M | -461M | 192M | 333M | 172M | -26.0M | -775M | 105M |
| EBITDA | 453M | 404M | 382M | -254M | 448M | 509M | 457M | 303M | -509M | 294M |
| Net Income | 1.00M | 114M | 505M | -508M | 220M | 927M | 178M | 169M | -845M | 4.00M |
| EPS | 0.02 | 1.78 | 8.02 | -8.33 | 3.61 | 17 | 3.30 | 3.38 | -18 | 0.09 |
| Balance Sheet | ||||||||||
| Total Assets | 8.62B | 8.25B | 7.25B | 6.88B | 6.61B | 6.21B | 5.94B | 5.65B | 4.61B | 4.53B |
| Total Liabilities | 5.21B | 4.85B | 3.68B | 3.84B | 3.86B | 2.99B | 2.84B | 2.78B | 2.71B | 2.68B |
| Shareholders' Equity | 3.41B | 3.41B | 3.57B | 3.04B | 2.75B | 3.22B | 3.10B | 2.87B | 1.90B | 1.85B |
| Cash & Short-term Investments | 566M | 294M | 232M | 454M | 210M | 646M | 417M | 300M | 215M | 480M |
| Total Debt | 2.82B | 2.53B | 1.67B | 1.99B | 2.10B | 1.38B | 1.46B | 1.47B | 1.58B | 1.47B |
| Cash Flow | ||||||||||
| Operating Cash Flow | 383M | 297M | 241M | 203M | 560M | -213M | 243M | 411M | 94.0M | 339M |
| Capital Expenditure | 199M | 157M | 154M | 138M | 105M | 113M | 170M | 137M | 98.0M | 88.0M |
| Free Cash Flow | 166M | 140M | 87.0M | 65.0M | 455M | -326M | 73.0M | 274M | -4.00M | 251M |
| Ratios | ||||||||||
| ROE | 0.0% | 3.3% | 14.1% | -16.7% | 8.0% | 28.8% | 5.7% | 5.9% | -44.4% | 0.2% |
| ROA | 0.0% | 1.4% | 7.0% | -7.4% | 3.3% | 14.9% | 3.0% | 3.0% | -18.3% | 0.1% |
| Net Profit Margin | 0.0% | 4.4% | 23.5% | -25.2% | 10.4% | 38.8% | 8.1% | 8.0% | -46.3% | 0.2% |
| Debt to Equity | 0.83x | 0.74x | 0.47x | 0.66x | 0.76x | 0.43x | 0.47x | 0.51x | 0.83x | 0.80x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Ashland Global Holdings Inc dividends
- Dividend yield
- 2.20%
- Forward dividend
- 1.68 USD
- Payout ratio
- 1,900.0%
- Ex-dividend date
- Sep 1, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | 76.0M | 1.65 | 1,900.0% |
| 2025 | USD 76.0M | 1.65 | - |
| 2024 | USD 78.0M | 1.56 | 46.2% |
| 2023 | USD 76.0M | 1.41 | 42.7% |
| 2022 | USD 70.0M | 1.25 | 7.6% |
| 2021 | USD 70.0M | 1.15 | 31.8% |
| 2020 | USD 66.0M | 1.08 | - |
| 2019 | USD 64.0M | 1.02 | 12.7% |
| 2018 | USD 60.0M | 0.94 | 52.6% |
| 2017 | USD 77.0M | 1.24 | 7,700.0% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 511:250 on May 15, 2017.
Who owns Ashland Global Holdings Inc
- Insiders 1.18%
- Institutions 98.82%
- Public & others 0.00%
- Shares outstanding 45.8M
- Free float 37.9M
Top funds holding ASH.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF | 1.65M | 3.59% | +0.05% | Oct 2026 |
| Franklin Small Cap Value A | 1.49M | 3.26% | 0.00% | Sep 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.31M | 2.86% | -10.36% | Sep 2026 |
| Avantis US Small Cap Value ETF | 1.22M | 2.66% | +3.52% | Oct 2026 |
| iShares Russell 2000 ETF | 1.17M | 2.56% | 0.00% | Oct 2026 |
| Scotia Wealth US Dividend Pool K | 1.01M | 2.21% | -10.88% | Jul 2026 |
| Vanguard Small Cap Index | 928K | 2.03% | -11.87% | Sep 2026 |
| DFA U.S. Small Cap Value I | 857K | 1.87% | +38.84% | Sep 2026 |
| MFS Mid Cap Value A | 762K | 1.66% | -0.80% | Sep 2026 |
| Thrivent Small Cap Stock A | 663K | 1.45% | -0.04% | Sep 2026 |
| Vanguard MStar Small Cap Value Index | 604K | 1.32% | -9.76% | Sep 2026 |
| Fidelity Small Cap Index | 509K | 1.11% | +0.17% | Aug 2026 |
| Diamond Hill Long-Short Inv | 494K | 1.08% | 0.00% | Sep 2026 |
| Franklin Small Cap Value VIP 1 | 467K | 1.02% | +1.96% | Sep 2026 |
| iShares Russell 2000 Value ETF | 437K | 0.95% | 0.00% | Oct 2026 |
| State Street® SPDR® S&P MIDCAP 400® ETF | 339K | 0.74% | +1.12% | Sep 2026 |
| DFA U.S. Targeted Value I | 330K | 0.72% | 0.00% | Sep 2026 |
| Nomura Small Cap Value A | 303K | 0.66% | 0.00% | Sep 2026 |
| Diamond Hill Select I | 285K | 0.62% | -2.26% | Sep 2026 |
| Vanguard Russell 2000 ETF | 270K | 0.59% | +1.14% | Sep 2026 |
Top institutions holding ASH.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| BlackRock Inc | 5.71M | 12.47% | +33.00% | Jun 2026 |
| 40 North Industries LLC | 4.53M | 9.88% | +72.38% | Jun 2026 |
| Franklin Templeton Inc | 3.62M | 7.90% | +107.56% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 2.63M | 5.74% | +5.70% | Sep 2026 |
| Vanguard Portfolio Management, LLC | 2.46M | 5.38% | +12.21% | Jun 2026 |
| Vanguard Capital Management, LLC | 2.06M | 4.51% | +0.51% | Jun 2026 |
| Massachusetts Financial Services Company | 2.04M | 4.45% | -27.61% | Jun 2026 |
| Frontier Capital Management CO Inc | 2.00M | 4.37% | +4.56% | Jun 2026 |
| Ancora Advisors LLC | 1.95M | 4.25% | +648,370.67% | Jun 2026 |
| Cooperman Leon G | 1.90M | 4.14% | +11.47% | Jun 2026 |
| State Street Corp | 1.89M | 4.13% | +22.84% | Jun 2026 |
| AQR Capital Management LLC | 1.82M | 3.98% | -9.35% | Jun 2026 |
| Diamond Hill Capital Management, LLC | 1.60M | 3.50% | -8.56% | Jun 2026 |
| 1832 Asset Management L.P | 1.41M | 3.08% | -0.44% | Jun 2026 |
| Geode Capital Management, LLC | 1.25M | 2.73% | +47.24% | Jun 2026 |
| Thrivent Financial For Lutherans | 1.03M | 2.25% | -0.06% | Jun 2026 |
| American Century Companies Inc | 919K | 2.01% | -19.41% | Jun 2026 |
| Northern Trust Corp | 760K | 1.66% | +56.63% | Jun 2026 |
| Empyrean Capital Partners, LP | 542K | 1.18% | 0.00% | Jun 2026 |
| Charles Schwab Investment Management Inc | 540K | 1.18% | +27.01% | Jun 2026 |
Ashland Global Holdings Inc company profile
- Company name
- Ashland Global Holdings Inc
- Ticker
- ASH.US
- Exchange
- USA Stocks
- Listed since
- Apr 6, 1983
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 2,800
- Fiscal year end
- September
- Address
- 8145 Blazer Drive, Wilmington, DE, United States, 19808
- Phone
- 302 995 3000
- Website
- ashland.com
About Ashland Global Holdings Inc
Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; agricultural chemicals; diagnostic films; and fine chemicals. Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. Its Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022. Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.
Ashland Global Holdings Inc management
10- Mr. Guillermo NovoChairman & CEO · born 1962
- Mr. William C. Whitaker C.F.A.Senior VP, CFO & Director of Investor Relations · born 1989
- Dr. Osama M. Musa Ph.D.Senior VP & CTO · born 1968
- Mr. James P. MinicucciSenior VP & GM of Personal Care · born 1982
- Ms. Alessandra Faccin AssisSenior VP and GM of Life Sciences & Intermediates · born 1980
- Mr. Wayne MuilSenior Vice President of Operations
- Mr. Samuel A. RichardsonVP, Controller & Principal Accounting Officer · born 1979
- Ms. Robin E. LampkinSenior VP, General Counsel & Secretary · born 1963
- Carolmarie C. BrownVice President of Corporate Affairs, Global Marketing, Brand & Business Communications
- Ms. Eileen M. DrurySenior VP & Chief HR Officer · born 1968